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Optimized methods are described for the analysis of glucose,
lactate, pyruvate, alanine, glycerol, D-3-hydroxybutyrate and
acetoacetate in perchloric acid extracts of human blood using the
Cobas Bio centrifugal analyser. Glucose and lactate are measured
using the photometric mode and other metabolites using the
fluorimetric mode. The intra-assay coefficients of variation ranged
from 0"7 to 4.1%, except with very low levels ofpyruvate and
acetoacetate where the coefficients of variation were 7"1 and 12%
respectively. All seven metabolites can be measured in a perchloric
acid extract of 20 l of blood. The methods have been optimized
with regard to variation in the perchloric acid content of the
samples. These variations arise from the method of sample
preparation used to minimize changes occurring in metabolite
concentration after venepuncture.
Introduction
effect ofpH and perchlorate on the activity ofeach of the
enzymes using spectrophotometric methods. In the light
of these findings existing fluorimetric methods were
modified and their performance evaluated. The use of
spectrophotometric rather than fluorimetric methods for
lactate and glucose was also investigated. From these
studies optimized automated methods have been
provided whereby unneutralized undiluted PCA extracts
of blood can be applied directly to the analyser.
Initially, the effect of pH and perchlorate on the
spectrophotometric assay each of the enzymes with each
substrate was examined. This established that any effect
on the enzyme activity was not simply due to changes in
fluorescence. The LKB Reaction Rate Analyser was
preferred for these experiments due to the ease in which
large changes in sample and reagent volumes can be
made.
Secondly, the reaction conditions were altered for the
fluorimetric metabolite analyses on the Cobas Bio, taking
account of the effects of pH and perchlorate on the
spectrophotometric methods.
Economical and specific measurement of the blood
concentrations of intermediary metabolites such as
acetoacetate, 3-hydroxybutyrate, glycerol, alanine and
pyruvate, as well as the more frequent measurement of
lactate and glucose, is of interest to the clinical chemist.
As some of these metabolites are present in low concen-
trations in human blood their accurate measurement in
small samples (50 1) requires the sensitivity of fluori-
metric methods, the required specificity being achieved
by using enzymatic reactions. Using both these tech-
niques with a centrifugal fast analyser, economic hand-
ling of large numbers of blood samples can be obtained.
Methods for this analyser have been described which
were adapted from continuous flow methods [2].
For all methods, the blood samples are deproteinized by
treatment with perchloric acid (PCA). Perchlorate,
however, interferes with the activity of the enzymes used
in the methods and as the perchlorate concentration may
vary in the samples, this in turn has an effect on the
observed concentration of the metabolite [3]. This paper
reports on an attempt to overcome the perchlorate
interference and optimize the centrifugal fast analyser
methods. To do this, it was necessary to examine the
Thirdly, it was demonstrated that photometric methods
were preferable to fluorimetric methods with metabolite
concentrations in excess of500 M. The latter could have
been overcome by using dilutions ofthe PCA extracts but
the aim was to establish a protocol whereby all seven
metabolites could be analysed automatically on a single
untreated PCA extract.
Materials
Lithium lactate grade L-X, sodium pyruvate Type II,
lithium acetoacetate and L-alanine were obtained from
Sigma Ltd (Poole, Dorset, UK); NAD, NADH, NADP,
ATP, D,L-3-hydroxybutyrate (monosodium salt), lactate
dehydrogenase (pig heart Cat. No. 107069), hexokinase
(yeast- Cat. No. 127817), L-alanine dehydrogenase (B
subtilis- Cat. No. 102636), glycerokinase (Candida
mycoderma Cat. No. 127795), 3-hydroxybutyrate
dehydrogenase (Rhodopseudomonas spheroides Cat.
No. 737054), glycerol-3-phosphate dehydrogenase (rab-
bit muscle- Cat. No. 127752) and glucose-6-phosphate
dehydrogenase (yeast- Cat. No. 127671) from BCL
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(Lewes, East Sussex, UK); with glycerol (AR), glucose
(50 mmol/1, 5 g/1 benzoic acid), perchloric acid- 600 g/kg
(AR) and all other chemicals from BDH (Poole, UK).
Sample preparation
About 1"5-2 ml of whole blood is added to a preweighed
plastic tube containing 5 ml of 0"77 mol/1 perchloric acid
previously cooled to 0 C. After mixing, the tubes were
reweighed, centrifuged at 2500 g for 5 min and the
protein-free supernatant removed. The dilution of the
blood is determined by the weight changes measured.
Alternatively, 0"5 ml whole blood may be added volu-
metrically to 2 ml 0"77 mol/1 perchloric acid and the
weighing omitted. For the metabolites, other than
acetoacetate, analysis of the samples is carried out on the
same day or the samples are stored at -20C.
Acetoacetate must be measured within 3 h ofcollection of
blood or the samples stored at -70 C.
Enzyme assay using theLKB Reaction Rate Analyser
To examine the possibility that the apparent difference in
metabolite concentration in the presence of variable
concentrations of perchlorate is due to interference in
fluorescence, rather than by a decreased enzyme activity,
measurements were made photometrically at 340 nm
using a LKB 8600 Reaction Rate Analyser at 37C
(Pharmacia LKB Biotechnology Division, Central
Milton Keynes, Buckinghamshire, UK). To determine
interference by perchlorate, various concentrations were
added to cuvettes containing coenzyme in buffered
substrate. To initiate the reaction the enzyme or enzymes
were injected, usually in a volume of 100 tl. In all cases,
the total volume in the cuvettes was ml and the
experimental conditions the concentrations referred to
are the final concentrations in the cuvettes.
Acetoacetate
The cuvettes contained 0"1 mol/1 sodium phosphate
buffer, pH 7"0 with 310 mol/1 NADH, 40 [amol/1 lithium
acetoacetate and 25-100 mmol/1 sodium perchlorate. 3-
Hydroxybutyrate dehydrogenase was added by the pump
to give 0" U/ml.
Pyruvate
The cuvettes contained 0"2 mol/1 triethanolamine and 5
mmol/1 EDTA, brought to pH 7"4 with 1"0 mol/1 HC1,
340 tmol/1NADH. 750 tmol/1 sodium pyruvate, and 25-
100 mmol/l sodium perchlorate. Lactate dehydrogenase
was added by the pump to give 8 mU/mol.
Lactate
The cuvettes contained 0"35 mol/1 glycine, 0"14 mol/1
hydrazinium chloride, 3"64 mol/1 EDTA, brought to pH
9"6 with 1"0 mol/1 NaOH, 7"5 mmol/l NAD, sodium
perchlorate, 25-100 mmol/1 and mmol/1 lithium lactate.
Lactate dehydrogenase was added by the pump to give 50
mU/ml.
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3-Hydroxybutyrate
The cuvettes contained 0"05 mol/1 Tris, 0"5 mol/1
hydrazine hydrate, 0"65 mmol/EDTA brought to pH 8"5
with 1"0 mol/HC1, 1"8 mmol/1 NAD, 4 mmol/1 sodium 3-
hydroxybutyrate and 25-100 mmol/1 sodium perchlorate.
3-Hydroxybutyrate dehydrogenase was added by the
pump to give 30 mU/ml.
Alanine
The cuvettes contained 0"02 mol/1 Tris, 0"5 mol/1
hydrazine hydrate, 0"65 mmol/1EDTA, brought to pH 10
with mol/1 HC1, 1"8 mmol/1 NAD, 10 mol/1 L-alanine
and 25-100 mmol/1 sodium perchlorate. Alanine dehy-
drogenase was added by the pump to give 10 mU/ml.
Glycerol
The cuvettes contained 0.6 mol/1 hydrazine hydrate, 0.12
mol/1 glycine, 6 mmol/1 MgC12 brought to pH 9"6 with "0
mol/1 NaOH, 1"5 mmol/1 NAD, 1"6 mmol/1 ATP,
mmol/1 glycerol and 25-100 mmol/1 sodium perchlorate.
Glycerokinase and glycerol-3-phosphate dehydrogenase
were added by the pump to give, respectively, 80 mU/ml
and 170 mU/ml. Both these enzymes were diluted from
stock in 0"04 mol/1 triethanolamine buffer pH 7"4 and
injected together.
Glucose
The cuvettes contained 0"05 mol/1 triethanolamine, 1.4
mmol/1 MgC12 adjusted to pH 8"0 with 10 mol/1 HC1,
1"65 mmol/1 NADP, 2"4 mmol/1 ATP, 2 mmol/1 glucose
and sodium perchlorate 25-100 mmol/1. Hexokinase, and
glucose-6-phosphate dehydrogenase were added by the
pump to give 140 mU/ml and 70 mU/ml respectively.
Both these enzymes were diluted from stock in 0"04 mol/1
triethanolamine buffer pH 7"4 and injected together.
The results for each metabolite are shown in table
where it can be seen that the glycerol, acetoacetate and
glucose assays are most susceptible to perchlorate.
pH Optima
When the blood is added to the perchloric acid the acid
concentration, as well as the perchlorate concentration of
the extract, varies from sample to sample. The extent to
Table 1. Effect ofsodium perchlorate: photometric methods.
Metabolite
Perchlorate concentration in cuvette,
mmol/1
0 25 50 75 100
% Activity
Glucose
Lactate
Pyruvate
3-Hydroxybutyrate
Glycerol
Alanine
Acetoacetate
100 84 56 41 25
100 94 85 78 71
100 98 95 91 89
100 90 81 73 69
100 72 62 5O 36
100 93 87 81 68
100 82 78 64 50R. Stappenbeck et al. Optimized methods using the Cobas Bio
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Figure 1. pH-activity curve for hydroxybutyrate dehydrogenase
using acetoacetate as substrate.
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Figure 2. pH-activity curve for lactate dehydrogenase using
pyruvate as substrate.
which the acidity affects the apparent concentration of a
metabolite depends on the activity-pH profile of the
enzymes under the experimental conditions used and the
buffer capacity. It was necessary therefore to determine
the pH profiles for each method to see if the variations in
pH found in the PCA extracts would result in relatively
large changes in the enzyme activity and hence the
apparent metabolite concentration. The pH activity
profiles for each assay as determined using the LKB
Reaction Rate Analyser are shown in figures 1-7. It is
clear that enzymes which show sharp peaks in the activity
curves, for example glycerol, will give metabolite assays
which are susceptible to variations in the pH of the PCA,
particularly with rate reaction methods where the
reaction does not go to completion. Clearly, those
enzymes which show little change in activity with pH
variation will provide metabolite assays much less
susceptible to variation in the pH of the extracts.
Perchloric acid effects in the methods using the
centrifugal analyser
The extent to which variations in the perchlorate acid
concentrations of the sample combined to alter the
apparent concentration of the metabolites were then
measured by conventional centrifugal analyser methods.
A series of standard solutions of the metabolites were
prepared, one set in 0.3 M PCA, one set in 0.4 M PCA,
one set in 0"3 M sodium perchlorate, another in 0"3 M
hydrochloric acid and a final set in water. The apparent
concentrations of the metabolites in these solutions were
measured by the methods previously described [1].
Table 2 shows that measurements of 3-hydroxybutyrate,
alanine, glycerol and acetoacetate were most affected by
perchlorate. An attempt was made to overcome the effect
by extending the reaction time, increasing the concen-
tration of the appropriate enzymes, and changing to end-
100
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8.0 8.2 8.4 8.6 8.8 9.0 9.2 9.4
pH
Figure 3. pH-activity curve for hydroxybutyrate dehydrogenase
using hydroxybutyrate as substrate.
point, rather than initial-rate, methods. For 3-
hydroxybutyrate, glycerol and acetoacetate these modifi-
cations were largely successful, and the best combination
of program parameters are shown in table 3. With the
alanine assay, despite a five-fold increase in the incuba-
tion time combined with a five-fold increase in the
enzyme concentration, complete conversion to pyruvate
could not be achieved. The parameters shown in table 3
are therefore those which substantially reduce the effect of
variations in PCA concentration and enable alanine
concentrations to be measured relatively economically.
As shown in figure 8, fluorescence measurements of
NADH and NADPH, at the levels present in the methods
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Figure 4. pH-activity curve for alanine dehydrogenase using
alanine as substrate.
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Figure 6. pH-activity curve for glycerol kinase/glycerol-3-
phosphate dehydrogenase using glycerol as substrate.
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Figure 5. pH-activity curve for lactate dehydrogenase using
lactate as substrate.
used for measuring lactate and glucose, gave non-linear
results with the Cobas Bio. The computer within the
instrument has a curve-fitting program, but as this non-
linearity could contribute to the overall imprecision in
these methods, it was decided to use spectrophotometry
rather than fluorimetry for the lactate and glucose
analyses.
For optimized direct.automated analysis of the metabo-
lites in PCA extracts ofblood, the methods are as follows.
0
7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5
pH
Figure 7. pH-activity curve for hexokinase/glucose-6-phosphate
dehydrogenase using glucose as substrate.
Acetoacetate
Main reagent: 500 btl 0"75 mg/ml NADH in 0"3 mol/1
sodium phosphate buffer pH 7"4 is added to 20 ml of the
same buffer.
Start reagent" 200 btl 3-hydroxybutyrate dehydrogenase
(7"5 U) is added to 400 btl water.
To set the PM voltage use water as sample and a
coenzyme reagent containing: 650 tl 0"75 mg/ml NADH
in 0"3 mol/1 sodium phosphate buffer pH 7"4 added to 20
ml of the same buffer.
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Table 2. Effect ofperchloric acid, sodium perchlorate and hydrochloric acid on the apparent concentration of metabolites.
Solutions used for
preparation of metabolites
Pyruvate Lactate Glucose BOH Glycerol Alanine Acetoacetate
50 tmol/1 1000 xmol/1 2"50 tmol/1 100 tmol/1 100 tmol/1 250 tmol/1 tmol/1
0"40 mol/1 Perchloric acid +2
0’70 mol/1 Perchloric acid +2
0"40 mol/1 Sodium perchlorate +7
0"70 mol/1 Sodium perchlorate +9
0"40 mol/1 Hydrochloric acid -7
0"70 mol/1 Hydrochloric acid 10
+1 +1 -17 -14 +10 -11
+ 0 -29 -23 + 10 18
+3 0 -20 -15 -7 -5
+ 0 -30 -26 15 16
+3 +1 -6 -1 +15 -8
+2 +2 -7 -2 +21 -4
The results are expressed as a percentage increase or decrease in the apparent concentration of the metabolite, as compared with that
found in aqueous solution of the same concentration.
Alanine
Main reagent: 0"04 mol/1 TRIS, mol/1 hydrazine
hydrate, 1"34 mmol/1 EDTA (disodium salt) adjusted to
pH 10"0 with 10 mol/1 hydrochloric acid.
Start reagent: 20 mg NAD and 100 tl alanine dehydroge-
nase (12 U) per 10 ml 0" mol/1 phosphate buffer pH 7"4.
The working reagent is prepared by adding 0"7 ml of this
solution to 8"8 ml of the buffer. This dilution is freshly
prepared for each batch of analyses and is warmed to
25C before use.
To set the PM voltage use a standard of 350 tmol/1.
Glucose
Main reagent: 0"1 mol/1 triethanolamine, 2 mmol/1
magnesium chloride, adjusted to pH 8"0 with 10 mol/1
hydrochloric acid.
Start reagent: 32 mg NADP, 37 mg ATP (disodium salt),
100 tl hexokinase (140 U) and 100 tl glucose-6-
phosphate dehydrogenase (70 U) per 10 ml 0"4 mol/1
triethanolamine buffer, pH 7"4. This solution is prepared
within h of use.
Glycerol
Main reagent: 0"2 mol/1 glycine, mol/1 hydrazine
hydrate, 10 mmol/1 magnesium chloride brought to pH
9"5 with 10 mol/1 sodium hydroxide.
Start reagent: 20 mg NAD, 20 mg ATP (disodium salt),
50 tl glycerokinase (21"3 U) and 100 tl glycerol-3-
phosphate dehydrogenase (170 U) per 10 ml 0"4 mol/1
triethanolamine buffer, pH 7"4. This mixture is prepared
immediately before use and should be at 25C when
applied to the analyser.
To set the PM voltage use a standard of 140 tmol/1.
Table 3. Program parameters.
Parameter ACAC Pyr Gluc Lact Ala Glyc BOH
Alpha Code 13(-) 13(-) 11(+) 11(+) 11(+) 11(+)
(1) Units 4 4 3 4 4 4 4
(2) Calculation factor 0 0 0 0 0 0 0
(3) Standard conc. 25 10 "50 200 50 20 20
(4) Standard 2 conc. 50 30 1.50 600 150 60 60
(5) Standard 3 conc. 100 60 3’00 1200 300 120 120
(6) Limit 150 65 3.2 1300 320 130 130
(7) Temperature, C 25 25 25 25 25 25 25
(8) Analysis mode 6 6 6 6 4 6 6
(9)* Wavelength, nm 340"2 340"2 340 340 340"2 340"2 340’2
(10) Sample volume, tl 20 10 5 5 10 5 5
11 Diluent volume, tl 20 10 25 25 20 25 25
(12) Reagent volume, lal 160 200 200 200 270 170 170
(13) Incubation time, 120 120 120 120 0 120 120
(14) Start volume, xl 20 10 20 20 0 20 20
(15) 1st reading time, ’5 "5 ’5 "5 "5 "5 "5
(16) Time interval, 60 60 60 60 60 60 60
(17) Number of readings 20 5 6 7 20 20 20
(18) Blanking mode
(19) Print-out mode 2
PMV** 380 508 532 660 520
All concentrations are in tmol/1 except glucose which is in mmol/l.
* The setting 340’2 is used in fluorescence modes to denote excitation wavelength 340 nm with emission filter position 2 (470 nm). The
lactate and glucose methods are photometric hence no filter position is required.
** PM voltages are for guidance only and may vary depending on the state of the instrument.
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Figure 8. Relationship between fluorescence intensity andNADH
concentration.
(’a) 0-2.4 #mol/l NADH.
(b) 0-100 #tool NADH.
Pyruvate
Main reagent: 32 tl mol/1 NADH in 0" mol/1 phosphate
buffer, pH 7"4 is added per 10 ml of 0"4 mol/1
triethanolamine buffer (0"4 mol/1 triethanolamine chlor-
ide, 10 mmol/l disodium EDTA adjusted to pH 7"4 with
10 mol/1 sodium hydroxide).
Start reagent: 63 tl lactate dehydrogenase (150 U) is
added per 10 ml 0"1 mol/1 phosphate buffer at pH 7.4.
Both coenzyme reagent and start reagent are prepared
immediately before use.
To set the PM voltage, use water as sample and a NADH
solution 20% more concentrated than used in the assay
proper, i.e. 38 tl g/1 NADH per 10 ml buffer.
Lactate
Main reagent" 0"5 mol/1 glycine, 0"2 mol/1 hydrazinium
chloride, 5"4 mmol/1 EDTA (disodium salt) adjusted to
pH 9"6 with 10 mol/1 sodium hydroxide.
Start reagent: 100 mg NAD and ml lactate dehydro-
genase (300 U) per 10 ml 0"1 mol/1 phosphate buffer at
pH 7"4. This is prepared immediately before use.
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Table 4. Intra-assay imprecision of analyses with optimized
methods.
Mean
tmol/1 CV N
Alanine 45"2 2"3 24
203 2"0 24
3-Hydroxybutyrate 20" 4" 21
99’3 2’6 25
Glycerol 19"9 4.4 24
92"7 1"9 24
Glucose 700 1"2 24
2270 1"3 24
Lactate 250 1"3 24
1106 0’7 24
Pyruvate 7"3 7"3 25
31"7 2"5 25
Acetoacetate 16 12"0 25
78 2"5 25
3-Hydroxybutyrate
Main reagent: 0"2 mol/1 TRIS, 0"1 mol/1 hydrazine
hydrate*, 2"7 mmol/1 EDTA (disodium salt) adjusted to
pH 8"9 with 10 mol/1 hydrochloric acid.
Start reagent: 20 mg NAD and 1"4 ml 3-hydroxybutyrate
dehydrogenase (7"5 U) per 10 ml 0.1 mol/1 phosphate
buffer, pH 7"4. This is prepared immediately before use.
To set the PM voltage use a standard of 140 tmol/1.
For the assays for alanine, glycerol and 3-
hydroxybutyrate, the relatively high blank fluorescence
makes it advisable to set the PM voltage using standard
solutions of concentrations up to 20% higher than the
respective top standards.
Standard solutions
Stock standards: 100 mmol/1 lithium lactate, 10 mmol/1
sodium pyruvate, 10 mmol/1D,L-3-hydroxybutyrate, 100
mmol/1 glycerol, 10 mmol/1 acetoacetate, 250 mmol/1 and
50 mmol/1 glucose alanine are prepared in deionized-
distilled water and diluted to the appropriate working
level with 0"46 mol/1 perchloric acid. All standards are
stored in a refrigerator at 4C for seven days. Working
standards containing all seven metabolites at the con-
centrations shown in table 3 are prepared on a daily basis.
Cobas Bio parametersfor optimized methods
It was found preferable to use print-out mode for all
analyses apart from alanine. With print-out mode 1, the
changes in fluorescence are related to the fluorescence of
the reaction mixture prior to addition ofthe start reagent;
with print-out mode 2 the changes in fluorescence are
related to the fluorescence of the reaction mixture 0"5 s
after addition ofthe start reagent. Ifvery rapid changes in
fluorescence occur, such as with samples ofhigh pyruvate
concentration, the change in fluorescence in the first 0"5 s
Although hydrazine has been used in the optimized method it may be
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Table 5. Effect ofperchloric acid, sodiumperchlorate and hydrochloric acid on the apparent concentration ofmetabolites: optimized methods.
Solutions used for
preparation of metabolites
Pyruvate Lactate Glucose BOH Glycerol Alanine Acetoacetate
50 [mol/1 1000 tmol/1 2’50 tmol/1 100 mol/1 100 [mol/1 250 mol/1 100 mol/1
0"40 mol/1 Perchloric acid +5
0’70 mol/1 Perchloric acid +3
0"40 mol/1 Sodium perchlorate +3
0’70 mol/1 Sodium perchlorate +3
0’40 mol/1 Hydrochloric acid +3
0"70 mol/1 Hydrochloric acid +1
-4 +1 -3 -1 +10 -5
-5 0 -6 -2 +10 -3
0 0 -6 -2 -8 0
0 0 -7 -3 -15 -4
-2 0 -4 -1 +15 -6
-2 +2 -2 -2 +21 0
The results are expressed as a percentage increase or decrease in the apparent concentration of the metabolite as compared with that
found in aqueous solution of the same concentration.
is significant and with print-out mode 2 an error is
introduced. This and the other changes in parameters are
included in table 3 where the parameters used for the
optimized methods are listed.
Evaluation of optimized methods
The intra-assay imprecision is shown in table 4. For
alanine, the parameters of the method are the same as
those described previously [1 ], consequently the data for
precision were not reassessed.
The effect of perchlorate, PCA and hydrochloric acid in
the sample were examined using the optimized methods
and the parameters listed in table 3. The concentrations
used were within the range likely to be found in extracts
using the standard method of sample collection where a
variable quantity of blood is added to 5 ml of 0"77 mol/1
perchloric acid. The results are shown in table 5.
Discussion
To determine the in vivo concentrations of metabolites
accurately it is necessary to make measurements im-
mediately after venepuncture. This can be done with the
biosensor systems now available to measure glucose [4]
and lactate [5] in whole blood. More usually, blood
samples are sent to a laboratory, which is often sited some
distance away, so there can be a delay between venepunc-
ture and analysis, incurring changes in metabolite
concentrations. Even when fluoride is added to blood,
stabilization is neither instantaneous nor complete,
although after the first hour the level can be kept
relatively stable at 4C for about 24 h, followed by a
further slow decrease [6]. Complete stability of glucose
and other metabolites is obtained ifthe blood proteins are
precipitated and the enzymes activated with PCA.
Storage at -20C of metabolites in PCA ensures a long
period of stability except for acetoacetate where the lower
temperature of-70C may be required [2].
The main disadvantages of such preparation of samples
are that perchlorate and acidity interfere with the activity
of the enzymes used in the subsequent methods. As
perchlorate affects both photometric and fluorimetric
measurement modes, interference in fluorescence charac-
teristics is not the explanation. One way to overcome the
problem of PCA can be to neutralize the samples by
titration with potassium carbonate or potassium hydrox-
ide, which precipitates the perchlorate. Precipitation may
not be complete and the neutralization procedure is in
any case time-consuming and increases the imprecision of
the technique. In addition it would require a significant
amount of sample preparation prior to automated
analysis, whereas the present aim was to reduce sample
handling to a minimum.
The differences in the perchlorate ion and acid concen-
tration of the perchloric acid extracts can be minimized
by pipetting a measured volume of blood into the PCA.
However, such a procedure is time-consuming and leads
to a delay in stabilization. In addition, the use ofpipettes
requires some degree of expertise, which those people
most likely to be taking blood may not have. Substituting
end-point methods for initial-rate methods overcomes the
inaccuracy due to the presence of different amounts of
PCA, except for alanine. With alanine the large amount
of enzyme and the long incubation time required makes
end-point analysis unacceptably expensive and time-
consuming. Fortuitously, the effects of acidity counteract
the effects of the perchlorate ion, so that in practice the
initial rate technique is the method of choice for alanine.
In general, end-point methods are less precise than
initial-rate methods. This is because the calculations in
the former are based on only two measurement, whereas,
in the latter, multiple measurements are made.
Initial-rate methods also use less enzyme and are quicker,
but these advantages can only be utilized when the PCA
concentration is exactly the same in samples and
standards. In addition, it is necessary to be very precise
about the activity of the enzyme used, and this should be
determined at frequent intervals. Wide variations can
occur in the activities of different batches of nominally
identical enzymes provided by the same supplier.
The concentrations of glucose and lactate in blood are
such that photometric methods can be used to measure
these two metabolites. This is preferred to the alternative
of diluting the sample and using fluorescence.
When large numbers of samples are being handled by
several persons, the method chosen to measure an analyte
is a compromise of various analytical ideals and objec-
tives. These optimized methods have been developed in
response to a first priority ofminimizing changes in blood
metabolites occurring after venepuncture, and, secondly,
to improve accuracy. The former requires that sample
219R. Stappenbeck et al. Optimized methods using the Cobas Bio
preparation can be made by persons who do not
necessarily have laboratory training and that blood is
added to PCA without delay. All the analyses can be
carried out without the need of further dilution. For
glucose, the imprecision is within the limit now regarded
as necessary for contemporary methods [7]. The other
methods give a within-batch precision which makes them
very useful. Some are slightly more prolonged and costly
than those previously described ], but they now provide
more reliable automated assays.
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